Providence Therapeutics

A clinical-stage #mRNA platform company developing #vaccines for #cancers and #InfectiousDiseases that pose public health risks

[Providence Therapeutics @ProvidenceThera]

Our President & CTO, Robert Georgantas III, Ph.D., was featured in a @DrugDiscovNews article highlighting the advantages of mRNA-based vaccines and our pipeline of vaccines in development for aggressive #cancers and #InfectiousDiseases. Read more here: https://t.co/KNyETxDWX7

[Providence Therapeutics @ProvidenceThera]

Our Chief Medical Officer, Aleksandra Pastrak, M.D., Ph.D., & Senior Research Associate, Kirstin Olsen, enjoyed presenting at this year’s #mRNA Based Therapeutics Summit in #Boston, where they had the opportunity to connect with others in the industry working on mRNA #research.

[Providence Therapeutics @ProvidenceThera]

Our Chief Medical Officer, Aleksandra Pastrak, M.D., Ph.D., and Senior Research Associate, Kirstin Olsen, will be presenting at the 3rd Annual #mRNA Based Therapeutics Summit in #Boston next Thursday and Friday. Learn more and register here: https://t.co/m1m2EdFswK

[Providence Therapeutics @ProvidenceThera]

We're proud to be a gold sponsor of the Western Canada RNA Conference, @RiboWest 2023, which brings together #RNA scientists from across #Canada and the northwestern United States. Our team will present on June 26 at 2:15 p.m. PT at @UNBC. Learn more here: https://t.co/xMJDUF8gtJ

[Providence Therapeutics @ProvidenceThera]

Our Chief Science Officer, Natalia Martin Orozco, Ph.D., will present at the Mexican Society of Immunology's 25th National Congress in Santiago de Querétaro, Mexico on Wednesday, June 7. Learn more here: https://t.co/andFr1WHmG @SMInmunologia

[Providence Therapeutics @ProvidenceThera]

Our Chief Financial Officer, Judyanna Yu, CPA, CA, and President & Chief Technology Officer, Robert Georgantas III, Ph.D., are enjoying connecting with industry leaders at the @IAmBiotech Convention. Reach out if you would like to meet: https://t.co/3KHvOFSlRj #BIO2023

[Providence Therapeutics @ProvidenceThera]

We are thrilled to announce our partnership with the University Health Network to develop mRNA-based vaccines and therapeutics for those living with difficult-to-treat #cancers and #InfectiousDiseases. Learn more about our collaboration with the @UHN here: https://t.co/ajKlJmTQ6X

[Providence Therapeutics @ProvidenceThera]

Our Chief Financial Officer, Judyanna Yu, CPA, CA, and President & Chief Technology Officer, Robert Georgantas III, Ph.D., look forward to meeting fellow industry leaders at the @IAmBiotech Convention. Reach out if you would like to meet us there: https://t.co/3KHvOFSTGR #BIO2023

[Providence Therapeutics @ProvidenceThera]

A new paper in @SciReports, an open-access part of the @NaturePortfolio, details the results of Providence's Phase 1 study of its mRNA-based COVID-19 vaccine candidate, the first clinical study to demonstrate encouraging data on Providence's mRNA platform: https://t.co/NA90QPIrhS

[Providence Therapeutics @ProvidenceThera]

Our President & Chief Technology Officer, Robert Georgantas III, Ph.D., is participating in @BioProcessOL upcoming panel to discuss the therapeutic #vaccine revolution and overcoming development and manufacturing challenges. Register for the panel here: https://t.co/G3xGXM3YmS

[Providence Therapeutics @ProvidenceThera]

Our Business Development Manager, Jordan Schwartz, Ph.D., spoke yesterday at the @MaRSDD Impact Health event. It was great to meet with and hear from others in the Canadian #healthcare innovation community! #MaRSImpactHealth

[Providence Therapeutics @ProvidenceThera]

Our CFO, Judyanna Yu, CPA, CA, and President & CTO, Robert Georgantas III, Ph.D., are attending @IAmBiotech's BIO International Convention in Boston from June 5-8. Please reach out if you’d like to meet us there: https://t.co/3KHvOFSlRj #BIO2023

[Providence Therapeutics @ProvidenceThera]

Happy National #Immunization Awareness Week! We're proud to support this campaign led by @ImmunizedotCa & @CPHA_ACSP highlighting the importance of routine immunizations to protect the Canadian population against vaccine-preventable diseases. #NIAW2023 #VaccinesWork #GetImmunized

[Providence Therapeutics @ProvidenceThera]

Our CFO, Judyanna Yu, CPA, CA, and BD Manager, Jordan Schwartz, Ph.D., are attending @Mintz_Law Early-Stage #LifeSciences Companies & Investors Networking Event in #Toronto on Monday, April 24. They look forward to meeting with investors at the event!

[Providence Therapeutics @ProvidenceThera]

Our CFO, Judyanna Yu, CPA, CA, and BD Manager, Jordan Schwartz, Ph.D., are attending the @bloomburton #Healthcare Investor Conference at the Metro #Toronto Convention Centre from April 25-26. Please reach out if you’d like to connect with us there! #BBHIC2023

[Providence Therapeutics @ProvidenceThera]

Welcome to the Providence Therapeutics Twitter page! Follow us for company updates and information about our #vaccines in development for #cancer and #InfectiousDiseases. Visit our website for more info: https://t.co/DbgBZlB55D